Skin cancer vaccine on the way: Cancer expert Prof Ian Frazer

In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year’ and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.

The 57-year-old immunology professor said, “In my lifetime we should be able to remove the threat of skin cancer from the next generation… The smoking gun evidence is there is a virus or viruses that cause it.” He said people can “catch” cancer from a virus. The greatest proof of this theory was the identification of the human papilloma virus (HPV) as the cause of cervical cancer.

Now he is using a similar tactic to try to combat skin cancer, including malignant melanomas. “This group of cancers caused by virus infection present a great opportunity because the idea of vaccinating to prevent a cancer is enormously appealing,” he said. Prof Frazer said the problem was two-fold. “Genetics and variations in people's immune systems may expose some people to greater risk of skin cancer after sun exposure…If you take away the body's defense systems, skin cancer becomes more common.”

His proposes that some viruses - particularly the wart virus or HPV - are embedded in the layers of the skin, which then pose a skin cancer risk for people with damaged immune systems. “The technology now exists for me to test my theory…It is very powerful but also very expensive. Using this tool, we will go hunting for the fingerprints of the virus or viruses present,” he explained. Prof Frazer's team will input all the sequenced genetic information on skin cancer - which will take six months - and then get an answer. “We will know if a virus causes skin cancer and what virus it is,” he assured.

To test his theory, Professor Frazer said he needed $20 million. So he and fellow University of Queensland professor, David Wilkinson, set up the skin cancer network - a group of the best medical experts pooling their knowledge and also seeking donations from philanthropists. Gordon Merchant, founder of the Billabong surf and skate wear empire, has already signed up, giving millions to the cause through the Merchant Foundation. “We have about half of what we need but I don't want to start until I know I can finish,” Professor Frazer said.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Skin cancer vaccine on the way: Cancer expert Prof Ian Frazer. News-Medical. Retrieved on October 17, 2021 from https://www.news-medical.net/news/20110731/Skin-cancer-vaccine-on-the-way-Cancer-expert-Prof-Ian-Frazer.aspx.

  • MLA

    Mandal, Ananya. "Skin cancer vaccine on the way: Cancer expert Prof Ian Frazer". News-Medical. 17 October 2021. <https://www.news-medical.net/news/20110731/Skin-cancer-vaccine-on-the-way-Cancer-expert-Prof-Ian-Frazer.aspx>.

  • Chicago

    Mandal, Ananya. "Skin cancer vaccine on the way: Cancer expert Prof Ian Frazer". News-Medical. https://www.news-medical.net/news/20110731/Skin-cancer-vaccine-on-the-way-Cancer-expert-Prof-Ian-Frazer.aspx. (accessed October 17, 2021).

  • Harvard

    Mandal, Ananya. 2018. Skin cancer vaccine on the way: Cancer expert Prof Ian Frazer. News-Medical, viewed 17 October 2021, https://www.news-medical.net/news/20110731/Skin-cancer-vaccine-on-the-way-Cancer-expert-Prof-Ian-Frazer.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Israeli Pfizer COVID vaccine/myocarditis study, 136 cases out of 5 million